logo
Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

Yahoo13-03-2025
Breakthrough Adjuvant AB-801 Secures 'Bioprocessing Excellence in Taiwan' Honor
TAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) -- New-generation Contract Development and Manufacturing Organization (CDMO) Amaran Biotech has been awarded the prestigious 'Bioprocessing Excellence in Taiwan' honor at the Asia-Pacific Biopharma Excellence Awards 2025 ceremony, hosted by renowned consulting firm IMAPAC in Singapore on March 12.
Established in 2017, the Asia-Pacific Biopharma Excellence Awards recognize outstanding achievements in bioprocessing, logistics, supply chain management, antibody-drug conjugates (ADC), and clinical trials experts, organizations and technologies across Asia. The awards aim to foster the advancement of the biopharmaceutical industry. Amaran Biotech's high-purity AB-801 adjuvant, produced through its innovative bioprocessing technology, triumphed after a process including nomination, shortlisting, and public voting.
An adjuvant is key component added to vaccines to enhance the body's immune response, boosting vaccine efficacy while reducing the required dosage per shot. Amaran Biotech's AB-801 offers application capabilities comparable to the globally recognized adjuvant QS-21, which is derived from the soap bark tree (Quillaja saponaria) native to Chile, Bolivia, and Peru. Saponin-based adjuvants have been utilized in several vaccines, including Shingrix® by GSK for shingles and the Novavax COVID-19 vaccine.
Dr. Tessie Che, Chairperson and General Manager of Amaran Biotech, stated: 'AB-801 is a GMP-grade QS-21 adjuvant, and we are one of the few CDMOs worldwide capable of manufacturing this product. This honor recognizes our team's dedication and hard work. We will continue to enhance our technologies to deliver high-quality bioprocessing solutions to global clients.' Currently, AB-801 is supplied to a leading pharmaceutical company worldwide, and has been adopted by research institutions and universities across Europe, North America, China, and Japan, as well as vaccine research organizations and manufacturers in China and India. Moving forward, Amaran Biotech will further expand its production capacity and ensure sustainable supply to serve more international clients and drive the global biotech industry forward.About Amaran BiotechAmaran Biotech is a CDMO specializing in drug process development, analytical services and cGMP manufacturing of high-value biopharmaceuticals. Amaran Biotech's state-of-the-art manufacturing facility is in the Hsinchu Biomedical Science Park and has been granted the PIC/S GMP certification from the TFDA since 2017. The company has also been audited and fully qualified by the regulatory agencies and third-party auditors from the USA and the EU. For more information, visit www.amaranbiotech.com
Media Contact: Doreen Lin doreen.lin@amaranbiotech.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5d0faf8b-ec8a-4f17-903d-30888555035fSign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global Experts Acknowledge TATA Wooden Door's Breakthrough in Urban Noise Control Through Scenario-Based Construction in China
Global Experts Acknowledge TATA Wooden Door's Breakthrough in Urban Noise Control Through Scenario-Based Construction in China

Yahoo

time12 minutes ago

  • Yahoo

Global Experts Acknowledge TATA Wooden Door's Breakthrough in Urban Noise Control Through Scenario-Based Construction in China

BEIJING, July 24, 2025--(BUSINESS WIRE)--On July, 2025, during the United Nations High-Level Political Forum on Sustainable Development, Dr. Zhang Qihua, President of the Global Alliance for Sustainable Development Foundation, pointed out in an interview: "As focus stays on air and water, WHO ranks urban noise as the second-biggest environmental health risk." Noise Pollution: A Neglected Global Health Threat. "In megacities over ten million, long-term noise exposure raises cardiovascular disease risk by 27%." "This directly hinders the achievement of SDG3 (Good Health and Well-being) and SDG11 (Sustainable Cities and Communities)." He emphasized that the acoustic environment is gaining attention in public health and governance. With 48% of residents suffering sleep disturbances, improving tranquility is no longer just technical—it's a systemic social task. Scenario-Based Innovation: A Chinese Breakthrough Approach In the relevant discussion, Dr. Zhang pointed out several outstanding cases from Chinese enterprises in reducing residential noise: "We have observed that some Chinese companies are exploring more adaptable noise-reduction solutions tailored to the structural characteristics of local housing." "For example, the Chinese brand TATA Wooden Door has developed quiet products tailored to family needs in small apartments, multi-generational homes, and elderly-friendly spaces. "Such approaches also offer reference value for other developing countries." He believes that the process of enabling residential scenarios through technology is not only a response to real pain points in families but also promotes the shift of 'quietness' from a single function to a lifestyle component. Global Collaboration to Promote the Popularization of the "Quiet Lifestyle" On how to promote the global adoption of the "quiet lifestyle," Dr. Zhang stated that the key lies in experience sharing and local adaptation. He believes that mature markets can share acoustic standards and governance mechanisms, while emerging markets offer valuable practices in product innovation and application scenarios. "Cases like TATA Wooden Door show that acoustic optimization isn't limited by technology and can be implemented sustainably based on needs." "Sharing practical cases through forums helps regions find suitable paths." "When people begin choosing quiet products aligned with their lifestyles, it becomes a meaningful step toward better living environments," Dr. Zhang concluded. View source version on Contacts Global Alliance for Sustainable Development Foundationhttps:// Gasdfund@ TATA Wooden DoorJiang Yutongservice@ Sign in to access your portfolio

Opendoor, Kohl's resume rally as meme stock frenzy continues
Opendoor, Kohl's resume rally as meme stock frenzy continues

Yahoo

time12 minutes ago

  • Yahoo

Opendoor, Kohl's resume rally as meme stock frenzy continues

(Reuters) -Shares of retail favorites Opendoor Technologies and Kohl's resumed their rally on Thursday, fueled by continued meme stock euphoria and broader markets hitting record highs. Opendoor Technologies, an e-commerce platform for residential real estate, rose 19% to $2.73, adding to its more than 400% surge in July. Bullish posts last week on by EMJ Capital portfolio manager Eric Jackson helped ignite the rally. 'This is not a meme stock,' Jackson wrote Thursday. '$OPEN is a real platform with real cashflow potential. The only question is how fast we push it to full value.' Struggling department store operator Kohl's, which joined the meme stock rally earlier in the week, jumped 10.5%. Donut chain Krispy Kreme gained 1.5%, while action camera maker GoPro edged up 0.3%. "You're getting some of the meme trade," said Thomas Hayes, chairman at Great Hill Capital LLC in New York. "The big early move was a short squeeze and now this is residual short squeeze followed by people starting to come and chase the momentum." Most of these companies are loss-making, making them targets for short sellers betting the shares will fall. However, retail traders often buy these cheaper stocks, sparking rapid rallies. When this occurs, short sellers are forced to unwind positions in a phenomenon known as a short squeeze. LSEG data show most of these firms are heavily shorted. Mom-and-pop traders bought GoPro and Krispy Kreme heavily on Wednesday, with Krispy Kreme seeing its biggest one-day inflow since May 2024. The recent moves revived memories of the Reddit-driven meme stock frenzy of 2021, when amateur investors pushed up shares of video-game retailer GameStop and cinema chain AMC, burning hedge funds that were on the other side of the trade. Sign in to access your portfolio

Missouri extends Eli Drinkwitz's contract through 2029, adds money to assistant salary pool
Missouri extends Eli Drinkwitz's contract through 2029, adds money to assistant salary pool

Yahoo

time12 minutes ago

  • Yahoo

Missouri extends Eli Drinkwitz's contract through 2029, adds money to assistant salary pool

Missouri football coach Eli Drinkwitz received a second contract extension in less than two years on Thursday, this one keeping him with the Tigers through the 2029 season while adding additional money to his salary pool for assistants. Drinkwitz signed an extension in December 2023 that paid him $46 million through the 2028 season, along with incentives such as $250,000 for a first-round appearance in the College Football Playoff and $750,000 for winning the national championship. 'I'm incredibly grateful for the continued belief in our vision,' said Drinkwitz, who is entering his sixth season at Missouri. 'I'm proud of the staff we've assembled and excited to keep pushing forward together.' Drinkwitz was the SEC coach of the year two years ago, when he led the Tigers to an 11-2 record and a Cotton Bowl win. They followed that up with a 10-3 record and a Music City Bowl win last season, giving the program back-to-back double-digit win seasons for the first time in a decade and only the third time in school history. Drinkwitz, who arrived in 2020 after one season leading Appalachian State, is 38-24 with the Tigers, breaking Dan Devine's record for the most wins in the first five seasons by a Missouri coach. He also has coached 17 players that were chosen in the NFL draft, including Armand Membou, the seventh overall pick of the New York Jets in April. 'The consistent progress we've seen under Coach Drinkwitz's leadership is inspiring,' Missouri athletic director Laid Veatch said in a statement. 'This extension, along with increased investment in our coaching and support staff, reflects our commitment to sustaining success at the highest level.' The Tigers open the season Aug. 28 against Central Arkansas with a roster that will have to replace numerous stars, including Membou, second-round pick Luther Burden III at wide receiver and Brady Cook at quarterback. But the Tigers have a favorable schedule with their first six games at home, including rival Kansas and SEC foes South Carolina and Alabama. The school is also undertaking a $250 million renovation of Faurot Field at Memorial Stadium due to be completed next year. 'Mizzou football is at a pivotal moment, marked in part by the historic Memorial Stadium Centennial Project,' Board of Curators chair Todd Graves said. 'Coach Drinkwitz is the right leader to ensure we uphold our championship culture and achieve wins that make Tiger fans proud across the state and around the world.' ___ Get poll alerts and updates on the AP Top 25 all season. Sign up here. AP college football: and

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store